Jeffrey Berkowitz Esperion Therapeutics, Inc. (ESPR) insider trading activity

ESPR Quotes by TradingView

Jeffrey Berkowitz is Director of Esperion Therapeutics, Inc.. Currently has a direct ownership of 23,449 shares of ESPR, which is worth approximately $54,636. The most recent transaction as insider was on May 27, 2021, when has been sold 12,376 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.4K
0% 3M change
0% 12M change
Total Value Held $54,636

Jeffrey Berkowitz Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 27 2021
BUY
Grant, award, or other acquisition
-
12,376 Added 34.55%
23,449 Common Stock
JB

Jeffrey Berkowitz

Director
Ann Arbor, MI

Track Institutional and Insider Activities on ESPR

Follow Esperion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ESPR shares.

Notify only if

Insider Trading

Get notified when an Esperion Therapeutics, Inc. insider buys or sells ESPR shares.

Notify only if

News

Receive news related to Esperion Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ESPR